Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,202 public trials 2,041 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Active, not recruiting

Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)

NCT05239741

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • Beijing Cancer hospital-Digestive Oncology ( Site 0001) Beijing, Beijing Municipality, China
  • Beijing Peking Union Medical College Hospital-Medical Oncology ( Site 0011) Beijing, Beijing Municipality, China
  • Tianjin Medical University Cancer Institute and Hospital-Gastric oncology ( Site 0019) Tianjin, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University ( Site 0051) Chongqing, Chongqing Municipality, China
View all 32 locations
View Trial Details
Active, not recruiting

Combination Immunotherapy in Colorectal Cancer

NCT05571293

Conditions
Colonic Diseases, Colorectal Neoplasms, Diabetes Mellitus, Insulin-Dependent, 12, +9 more
Locations
  • Weill Cornell Medicine/New York-Presbyterian Brooklyn Methodist Hospital Brooklyn, New York, United States
  • Weill Cornell Medicine/NewYork Presbyterian - Queens Flushing, New York, United States
  • Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States
View Trial Details
Active, not recruiting

Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer

NCT04503694

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +10 more
Locations
  • Institut Jules Bordet Anderlecht, Belgium
  • Chirec Delta Brussels, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • UZAntwerpen Edegem, Belgium
View Trial Details
Active, not recruiting

The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER)

NCT06699836

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • Pacific Hematology Oncology Associates San Francisco, California, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Norton Cancer Institute, Brownsboro Hospital Campus Louisville, Kentucky, United States
View Trial Details
Active, not recruiting

Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer

NCT06157216

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Qilu Hospital of Shandong Univertisy Jinan, Shandong, China
  • Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan, Shandong, China
  • Jinan Central Hospital Jinan, Shandong, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details

Related conditions